Finucane J
Ir J Med Sci. 2016; 145(1):195.
PMID: 27517228
DOI: 10.1007/BF02938944.
Weissel M
Wien Klin Wochenschr. 2014; 126(9-10):311-9.
PMID: 24652010
DOI: 10.1007/s00508-014-0515-7.
Wellby M, OHalloran M
Br Med J. 2010; 2(5515):668-70.
PMID: 20791108
PMC: 1943864.
DOI: 10.1136/bmj.2.5515.668.
Acland J
J Clin Pathol. 1971; 24(3):187-218.
PMID: 16811063
PMC: 476957.
DOI: 10.1136/jcp.24.3.187.
Nicoloff J, Dowling J
J Clin Invest. 1968; 47(1):26-37.
PMID: 16695944
PMC: 297145.
DOI: 10.1172/JCI105712.
Total and free triiodothyronine in human serum.
Nauman J, Nauman A, WERNER S
J Clin Invest. 1967; 46(8):1346-55.
PMID: 16695923
PMC: 297136.
DOI: 10.1172/JCI105627.
Thyroxine Turnover and Transport in Laennec's Cirrhosis of the Liver.
Inada M, Sterling K
J Clin Invest. 1967; 46(8):1275-82.
PMID: 16695916
PMC: 297129.
DOI: 10.1172/JCI105620.
Hyperthyroidism with normal serum total T4, T3, and thyroid binding protein concentration.
Caro J, SLOANE N, Glennon J
J Clin Pathol. 1980; 33(9):868-70.
PMID: 6776158
PMC: 1146248.
DOI: 10.1136/jcp.33.9.868.
Euthyroid hyperthyroxinemia.
Rajatanavin R, Braverman L
J Endocrinol Invest. 1983; 6(6):493-505.
PMID: 6368663
DOI: 10.1007/BF03348351.
Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients.
Socolow E, Woeber K, Purdy R, Holloway M, Ingbar S
J Clin Invest. 1965; 44(10):1600-9.
PMID: 5840530
PMC: 292644.
DOI: 10.1172/JCI105266.
[Determination of free thyroxine in the serum using I-125 marked thyroxine].
Herrmann J, KRUSKEMPER H
Klin Wochenschr. 1968; 46(23):1285-6.
PMID: 5714782
DOI: 10.1007/BF01711878.
The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.
Woeber K, Sobel R, Ingbar S, Sterling K
J Clin Invest. 1970; 49(4):643-9.
PMID: 5467580
PMC: 322518.
DOI: 10.1172/JCI106275.
Differences in primary cellular factors influencing the metabolism and distribution of 3,5,3'-L-triiodothyronine and L-thyroxine.
OPPENHEIMER J, Schwartz H, Shapiro H, Bernstein G, SURKS M
J Clin Invest. 1970; 49(5):1016-24.
PMID: 5441537
PMC: 535753.
DOI: 10.1172/JCI106301.
The distribution kinetics of triiodothyronine: studies of euthyroid subjects with decreased plasma thyroxine-binding globulin and patients with Graves' disease.
CAVALIERI R, Steinberg M, SEARLE G
J Clin Invest. 1970; 49(6):1041-50.
PMID: 4987168
PMC: 322572.
DOI: 10.1172/JCI106320.
The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man.
Woeber K, Hecker E, Ingbar S
J Clin Invest. 1970; 49(4):650-4.
PMID: 4986213
PMC: 322519.
DOI: 10.1172/JCI106276.
Effect of epinephrine on the peripheral metabolism of thyroxine.
Hays M, Solomon D
J Clin Invest. 1969; 48(6):1114-23.
PMID: 4977031
PMC: 322326.
DOI: 10.1172/JCI106068.
Studies on human thyroxine-binding globulin (TBG). I. Purification of TBG and immunologic studies on the relationship between TBG from normal persons and those with TBG "deficiency".
Marshall J, Pensky J
J Clin Invest. 1969; 48(3):508-15.
PMID: 4975158
PMC: 535715.
DOI: 10.1172/JCI106008.
The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption.
Woeber K, Ingbar S
J Clin Invest. 1968; 47(7):1710-21.
PMID: 4968803
PMC: 297327.
DOI: 10.1172/JCI105861.
Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I.
OPPENHEIMER J, Bernstein G, Hasen J
J Clin Invest. 1967; 46(5):762-77.
PMID: 4960936
PMC: 297079.
DOI: 10.1172/JCI105577.
Lack of significant binding of L-triiodothyronine by thyroxine-binding globulin in vivo as demonstrated by acute disappearance of 131-I-labeled triiodothyronine.
ZANINOVICH A, Farach H, EZRIN C, Volpe R
J Clin Invest. 1966; 45(8):1290-301.
PMID: 4958993
PMC: 292805.
DOI: 10.1172/JCI105436.